Yahoo Web Search

Search results

    • Q1 2024 BioNTech SE Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 7 days ago

      Second, targeted therapies, which include CAR T cell therapies and antibody drug conjugate that can dramatically reduce the tumor burden. The third category are mRNA